Sort
40,608 grants matching “prostate cancer”
ABERRANT REGULATION OF CATHEPSIN B EXPRESSION IN TUMORS
$576,108Wayne State University · R01 · FY2003 · CA
Hybrid Nanoparticles in Imaging and Therapy of Prostate*
$576,101Kattesh V Katti · University Of Missouri-Columbia · R01 · FY2009 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies
$576,083Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer
$576,069Jay H Fowke · Vanderbilt University · R01 · FY2007 · CA
Tissue ProcessingSequencing Core
$576,068Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Characterizing Prostate Cancer By ex vivo MRS Signatures
$576,016Leo L Cheng · Massachusetts General Hospital · R01 · FY2013 · CA
Molecular Signatures of Lethal and Indolent Prostate Cancer
$576,014Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · CA
ROLE OF THE TUMOR NEUROENVIRONMENT IN PROSTATE CANCER METASTASIS
$576,001Cold Spring Harbor Laboratory · · FY2022 · Department of the Army
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$575,937Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Early clinial trials for Angelica herbal supplements for prostate cancer interception
$575,924Junxuan Lu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA
A NEIGHBORHOOD-BASED INTERVENTION TO REDUCE PROSTATE CANCER DISPARITIES
$575,845Thomas Jefferson University · · FY2015 · Department of Defense
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$575,750Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2023 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$575,750Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2025 · CA
Accuracy of Physical Activity Measures in Cancer Studies
$575,714Barbara Sternfeld · Kaiser Foundation Research Institute · R01 · FY2006 · CA
Peptoid conjugates targeting prostate cancer
$575,698Michael J Garabedian · New York University School Of Medicine · R01 · FY2025 · CA
3-dimensional prompt gamma imaging for online proton beam dose verification
$575,694Lei Ren · University Of Maryland Baltimore · R01 · FY2023 · CA
Defining Tumor Microenvironmental Mediators of Prostate Cancer Metastasis and Therapy Resistance
$575,652Paula Jill Hurley · Vanderbilt University Medical Center · R01 · FY2024 · CA
Quality of Life of African American Cancer Survivors
$575,644University Of Illinois At Chicago · R01 · FY2003 · CA
REDOX STRESS-MEDIATED INAPPROPRIATE ANDROGEN RECEPTOR ELEVATION AS A NOVEL TREATMENT PARADIGM FOR CASTRATION-RESISTANT PROSTATE CANCER
$575,625University Of Miami · · FY2016 · Department of the Army
TYROSINE PHOSPHORYLATION OF TUBULIN ISOFORM AND THERAPEUTIC RESISTANCE IN PROSTATE CANCER
$575,625University Of Maryland, Baltimore · · FY2015 · Department of Defense
THE FUNCTION OF AR-NEGATIVE CANCER STEM CELLS IN PROSTATE CANCER
$575,625Cincinnati Univ Of · · FY2008 · Department of the Army
DJ-1IN THE DEVELOPMENT OF HORMONE-REFRACTORY PROSTATE CANCER
$575,625Cincinnati Univ Of · · FY2008 · Department of the Army
GLYCOMIC ANALYSIS OF PROSTATE CANCER
$575,625Georgetown University · · FY2009 · Department of the Army
REPURPOSING DRUGS FOR PROSTATE CANCER THERAPY
$575,618University Of Miami · · FY2014 · Department of Defense
Johns Hopkins University NCTN Lead Academic Site Program
$575,595Julie Renee Brahmer · Johns Hopkins University · U10 · FY2018 · CA